Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Oncology Venture Sweden agrees to inlicense dovitinib from Novartis

April 10, 2018

Gruenenthal enters nonopioid drug collaboration with KU Leuven

April 10, 2018

Ionis licenses drug candidate for NASH to AstraZeneca

April 10, 2018

Allogene Therapeutics finalizes CAR T therapy asset transaction with Pfizer

April 10, 2018

Takara Bio and Otsuka to codevelop NY-ESO-1 siTCR and CD19 CAR gene therapy

April 9, 2018

Servier enters agreement with and Scandicure to conduct research in the field of metabolic diseases

April 9, 2018

Recordati acquires rights to Cystagon

April 9, 2018

FunPep enters option agreement on antibody-inducing peptides with Sumitomo Dainippon Pharma

April 9, 2018

Iontas to collaborate with Igem to identify novel IgE antibodies

April 9, 2018

Takeda and DNDi collaborate to develop potential novel drug for visceral leishmaniasis

April 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.